Skip to main content Accessibility help
×
Home

Risk Factors for Peripheral Intravenous Catheter Failure: A Multivariate Analysis of Data from a Randomized Controlled Trial

  • Marianne C. Wallis (a1) (a2), Matthew McGrail (a3), Joan Webster (a2) (a4), Nicole Marsh (a2) (a4), John Gowardman (a5), E. Geoffrey Playford (a6) and Claire M. Rickard (a2)...

Abstract

Objective.

To assess the relative importance of independent risk factors for peripheral intravenous catheter (PIVC) failure.

Methods.

Secondary data analysis from a randomized controlled trial of PIVC dwell time. The Prentice, Williams, and Peterson statistical model was used to identify and compare risk factors for phlebitis, occlusion, and accidental removal.

Setting.

Three acute care hospitals in Queensland, Australia.

Participants.

The trial included 3,283 adult medical and surgical patients (5,907 catheters) with a PIVC with greater than 4 days of expected use.

Results.

Modifiable risk factors for occlusion included hand, antecubital fossa, or upper arm insertion compared with forearm (hazard ratio [HR], 1.47 [95% confidence interval (CI), 1.28–1.68], 1.27 [95% CI, 1.08–1.49], and 1.25 [95% CI, 1.04–1.50], respectively); and for phlebitis, larger diameter PIVC (HR, 1.48 [95% CI, 1.08–2.03]). PIVCs inserted by the operating and radiology suite staff had lower occlusion risk than ward insertions (HR, 0.80 [95% CI, 0.67–0.94]). Modifiable risks for accidental removal included hand or antecubital fossa insertion compared with forearm (HR, 2.45 [95% CI, 1.93–3.10] and 1.65 [95% CI, 1.23–2.22], respectively), clinical staff insertion compared with intravenous service (HR, 1.69 [95% CI, 1.30–2.20]); and smaller PIVC diameter (HR, 1.29 [95% CI, 1.02–1.61]). Female sex was a nonmodifiable factor associated with an increased risk of both phlebitis (HR, 1.64 [95% CI, 1.28–2.09]) and occlusion (HR, 1.44 [95% CI, 1.30–1.61]).

Conclusions.

PIVC survival is improved by preferential forearm insertion, selection of appropriate PIVC diameter, and insertion by intravenous teams and other specialists.

Trial Registration.

The original randomized controlled trial on which this secondary analysis is based is registered with the Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au; ACTRN12608000445370).

Copyright

Corresponding author

School of Nursing and Midwifery, University of the Sunshine Coast, Locked Bag 4, Maroochydore DC, Queensland 4558, Australia (mwallis@usc.edu.au)

References

Hide All
1. Grüne, F, Schrappe, M, Basten, J, Wenchel, HM, Tuai, E, Stützer, H. Phlebitis rate and time kinetics of short peripheral intravenous catheters. Infection 2004;32(1):3032.
2. Pujol, M, Homero, A, Sabalis, M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect 2007;67(1):2229.
3. Ritchie, S, Jowitt, D, Roberts, S. The Auckland City Hospital Device Point Prevalence Survey 2005: utilisation and infectious complications of intravascular and urinary devices. N Z Med J 2007;120(1260):U2683U2683.
4. Hadaway, L. Short peripheral intravenous catheters and infections. J Infus Nurs 2012;35(4):230240.
5. Limm, EI, Fang, X, Dendle, C, Stuart, RL, Egerton Warburton, D. Half of all peripheral intravenous lines in an Australian tertiary emergency department are unused: pain with no gain? Ann Emerg Med 2013;62:521525.
6. Waitt, C, Waitt, P, Pirmohamed, M. Intravenous therapy. Postgrad Med 2004;80(939):16.
7. Bregenzer, T, Conen, D, Sakmann, P, Widmer, AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998;158(2):151156.
8. Collignon, PJ, Dreimanis, DE, Beckingham, WD, Roberts, JL, Gardner, A. Intravascular catheter bloodstream infections: an effective and sustained hospital-wide prevention program over 8 years. Med J Aust 2007;187(10):551554.
9. Tagalakis, V, Kahn, SR, Libman, M, Blostein, M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 2002;113(2):146151.
10. Webster, J, Clarke, S, Paterson, D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ 2008;337:a339a339.
11. Zingg, W, Pittet, D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents 2009;34(suppl 4): S38S42.
12. Maki, DG, Ringer, M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991;114(10):845854.
13. Van Donk, P, Rickard, CM, McGrail, MR, Doolan, G. Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: a randomized controlled trial. Infect Control Hosp Epidemiol 2009;30(9):915917.
14. Webster, J, Lloyd, S, Hopkins, T, Osborne, S, Yaxley, M. Developing a research base for intravenous peripheral cannula re-sites (DRIP trial): a randomised controlled trial of hospital in-patients. Int J Nurs Stud 2007;44(5):664671.
15. Comely, OA, Bethe, U, Pauls, R, Waldschmidt, D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002;23(5):249253.
16. Dillon, MF, Curran, J, Martos, R, et al. Factors that affect longevity of intravenous cannulas: a prospective study. QJM 2008;101(9):731735.
17. Kagel, EM, Rayan, GM. Intravenous catheter complications in the hand and forearm. J Trauma 2004;56(1):123127.
18. Rickard, CM, Webster, J, Wallis, MC, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet 2012;380(9847):10661074.
19. Prentice, RL, Williams, BJ, Peterson, AV. On the regression analysis of muyltivariate failure time data. Biometrika 1981;68(2):373379.
20. O'Grady, NP, Alexander, M, Burns, LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39(4 suppl 1):S1S34.
21. Infusion Nursing Standards of Practice. J Infus Nurs 2011;34(1S): S1S109.
22. da Silva, GA, Priebe, S, Dias, FN. Benefits of establishing an intravenous team and the standardization of peripheral intravenous catheters. J Infus Nurs 2010;33(3):156160.
23. Soifer, NE, Borzak, S, Edlin, BR, Weinstein, RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998;158(5):473477.
24. Jarvis, WR. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. J Hosp Infect 2007;65(suppl 2):39.
25. Boyd, S, Aggarwal, I, Davey, P, Logan, M, Nathwani, D. Peripheral intravenous catheters: the road to quality improvement and safer patient care. J Hosp Infect 2011;77(1):3741.
26. Maki, DG. Improving the safety of peripheral intravenous catheters. BMJ 2008;337:a630a630.
27. Smith, B. Peripheral intravenous catheter dwell times: a comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infus Nurs 2006;29(1):1417.

Risk Factors for Peripheral Intravenous Catheter Failure: A Multivariate Analysis of Data from a Randomized Controlled Trial

  • Marianne C. Wallis (a1) (a2), Matthew McGrail (a3), Joan Webster (a2) (a4), Nicole Marsh (a2) (a4), John Gowardman (a5), E. Geoffrey Playford (a6) and Claire M. Rickard (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed